A skin biopsy can detect skin cancers, autoimmune diseases, infections, inflammatory conditions, and even signs of systemic illnesses affecting other parts of the body. It works by removing a small sample of skin tissue so a pathologist can examine the cells under a microscope, identifying abnormalities that aren’t visible from the surface alone. The range of conditions it can diagnose is surprisingly broad.
Skin Cancer
Cancer detection is the most common reason for a skin biopsy. The three major types it identifies are basal cell carcinoma, squamous cell carcinoma, and melanoma. Basal cell carcinoma is the most common skin cancer, forming in the lower layer of the outer skin and typically appearing on the face, head, neck, and arms. Squamous cell carcinoma forms in the upper layer of the outer skin and, like basal cell, rarely spreads. Melanoma is less common but more dangerous because it’s more likely to spread to other parts of the body. It develops in the pigment-producing cells that give skin its color.
In one large study of biopsied lesions, 66% of detected cancers were basal cell carcinomas, 29% were squamous cell carcinomas, and 4% were melanomas. Beyond these three, a biopsy can also identify rarer skin cancers like Merkel cell carcinoma, sebaceous carcinoma, and cutaneous T-cell lymphoma.
The biopsy doesn’t just confirm whether cancer is present. The pathologist also evaluates margins, meaning how close the cancer cells are to the edges of the removed tissue. Negative margins indicate that normal, cancer-free tissue surrounds the tumor on all sides, suggesting the cancer was fully removed. Positive margins mean cancer cells extend to the edge of the sample, which typically calls for additional surgery.
Precancerous and Benign Growths
Not every biopsy reveals cancer. Many are performed to determine whether a suspicious spot is something harmless or something that needs attention. Actinic keratoses are rough, scaly patches caused by years of sun exposure that can develop into squamous cell carcinoma if left untreated. A biopsy can confirm whether a lesion is still precancerous or has already progressed. It also identifies benign growths like seborrheic keratoses (waxy, raised spots common with aging), skin tags, lipomas, moles, and keloid scars.
Autoimmune and Inflammatory Conditions
A skin biopsy is one of the most useful tools for diagnosing autoimmune and inflammatory diseases that show up on the skin. In a review of over 400 skin biopsies related to rheumatic diseases, the most commonly diagnosed conditions were psoriasis (about 12% of cases), discoid lupus (about 12%), and vasculitis, which is inflammation of blood vessels (about 11%). Morphea, a condition that causes hardened patches of skin, accounted for roughly 4% of cases.
For conditions like lupus and dermatomyositis (an inflammatory disease causing skin rashes and muscle weakness), a biopsy can reveal characteristic patterns of inflammation and immune cell activity that clinch the diagnosis when blood tests and physical exams aren’t enough on their own. Blistering disorders like pemphigus and bullous pemphigoid, where the immune system attacks layers of the skin and causes fragile blisters, also require a biopsy for confirmation. The pathologist looks for specific antibody deposits within the skin layers.
Other inflammatory conditions a biopsy can identify include lichen planus, granuloma annulare, sarcoidosis, and pyoderma gangrenosum.
Infections
When a skin infection doesn’t respond to treatment or looks unusual, a biopsy can identify the specific organism responsible. Fungal infections that have penetrated deeper than the surface, certain bacterial infections, and viral conditions can all be confirmed through tissue analysis. The pathologist may use special stains on the tissue sample to highlight bacteria, fungi, or viral changes that wouldn’t be visible with standard staining techniques. Conditions like deep fungal infections, atypical bacterial infections, and folliculitis (infected hair follicles) are among those diagnosed this way.
Signs of Systemic Disease
Because the skin is the body’s largest and most accessible organ, it sometimes offers the first clue that something is going wrong internally. A skin biopsy can reveal evidence of diseases affecting the whole body. Sarcoidosis, for instance, causes clusters of inflammatory cells called granulomas that can appear in skin tissue before other symptoms develop. Vasculitis detected through skin biopsy, such as the small-vessel inflammation seen in Henoch-Schönlein purpura, may point to broader involvement of the kidneys or joints.
Certain genetic and connective tissue disorders also leave identifiable patterns in the skin. Ehlers-Danlos syndrome, which affects the structure of collagen throughout the body, can be supported by biopsy findings. Rare conditions like nephrogenic systemic fibrosis, linked to certain contrast agents used in medical imaging, produce distinctive skin thickening that a biopsy can confirm.
How the Biopsy Type Affects What’s Found
The technique your doctor chooses depends on what they suspect and how deep the problem goes. A shave biopsy skims a thin layer from the surface, less than 1 millimeter deep. It works well for conditions limited to the outermost skin layer: warts, skin tags, superficial basal or squamous cell carcinomas. A punch biopsy uses a small circular blade to extract a full-thickness core of skin, reaching down through all layers and sometimes into the fat beneath. This is the go-to method for inflammatory conditions, blistering diseases, and anything that requires seeing the deeper tissue architecture.
A saucerization biopsy removes a thicker disk of tissue, typically 1 to 4 millimeters deep, and is often used for flat or pigmented lesions. For suspected melanoma, an excisional biopsy removes the entire suspicious area along with a margin of normal tissue surrounding it. This approach ensures the pathologist can assess the full depth of the lesion and check those margins for cancer-free borders.
What Results Look Like
Results typically come back within one to two weeks, though more complex cases requiring special stains or additional expert review can take longer. Your pathology report will describe the type of cells found, any abnormalities in their appearance or arrangement, and whether the findings point to a specific diagnosis.
For cancer biopsies, the report will note the type of cancer, how deep it extends into the skin, and the status of the margins. For inflammatory or autoimmune conditions, it will describe the pattern and location of inflammation, the types of immune cells involved, and whether antibody deposits are present. Sometimes a biopsy narrows the possibilities without giving one definitive answer, and your doctor may combine the findings with blood work, imaging, or clinical history to reach a final diagnosis.
A result labeled “atypical” means the cells look abnormal but don’t clearly meet the criteria for cancer. This is common with unusual moles and may lead to a follow-up biopsy or closer monitoring rather than immediate treatment.